FEV1 severity grading (% predicted): mild ____, moderate ____, moderately severe ____, severe ____, very severe <____.

Obstruction severity by FEV1 % predicted: mild 70-79, moderate 60-69, moderately severe 50-59, severe 35-49, very severe <35.

MKSAP 19 B.5 Ch.1 (Table 1)

DLCO severity: mild is below the LLN but above ____% of predicted, moderate is ____-____%, and severe is below ____%.

DLCO severity: mild = below the LLN but above 60% of predicted; moderate 40-60%; severe below 40%.

MKSAP 19 B.5 Ch.1 (Table 1)

A positive bronchodilator response requires an increase in FEV1 or FVC of at least ____% AND at least ____ mL.

A positive bronchodilator response = an increase in FEV1 or FVC of at least 12% AND at least 200 mL from baseline. Both criteria must be met.

MKSAP 19 B.5 Ch.1; Harrison's 22e Ch.296

The ATS defines the lower limit of normal as below the ____th percentile of predicted, which roughly coincides with ____% of predicted.

The ATS defines the LLN as below the 5th percentile of the predicted value, which roughly coincides with 80% of predicted; values below it indicate impairment.

MKSAP 19 B.5 Ch.1

Methacholine challenge is positive when FEV1 falls by ____% or more from baseline; its chief value is a high ____ for ruling out asthma.

Bronchial challenge testing is positive when FEV1 falls by 20% or more from baseline. Its main strength is a high negative predictive value for ruling out asthma; positives are nonspecific (COPD, smoking, URI, rhinitis, bronchiectasis, CF).

MKSAP 19 B.5 Ch.1

FeNO above ____ ppb indicates glucocorticoid-sensitive airway inflammation; below ____ ppb makes eosinophilic inflammation unlikely.

ATS FeNO cutoffs: above 50 ppb indicates glucocorticoid-sensitive eosinophilic airway inflammation; below 25 ppb makes eosinophilic inflammation and steroid responsiveness unlikely. Recommended as an adjunct from age 5.

MKSAP 19 B.5 Ch.1

Three causes of elevated DLCO: diffuse alveolar ____, left-to-right ____, and ____ (also polycythemia).

DLCO rises with increased pulmonary capillary blood volume or intra-alveolar hemoglobin: diffuse alveolar hemorrhage, left-to-right shunts, asthma, and polycythemia.

MKSAP 19 B.5 Ch.1; Harrison's 22e Ch.296

Normal SpO2 is ____-____%; values below ____% indicate hypoxemia.

Normal SpO2 is 95-100%; values below 90% indicate hypoxemia. Erroneous readings come from carboxyhemoglobin (CO poisoning), methemoglobin (nitrates), methylene blue, cool extremities, poor perfusion, nail polish, and motion.

MKSAP 19 B.5 Ch.1

For interstitial lung disease order ____-resolution CT; it must NOT be used for lung ____ because it skips lung sections.

High-resolution CT (1 mm slices) is preferred for interstitial lung disease but skips lung sections, so it must NOT be used to evaluate lung nodules — use routine noncontrast CT (2-2.5 mm) for those. CT angiography (timed contrast bolus) is for pulmonary embolism.

MKSAP 19 B.5 Ch.1

PET cannot characterize nodules under ____ mm; two classic false-negative tumors are carcinoid and adenocarcinoma ____ ____.

PET is not useful for nodules under 8 mm. False positives: infection/inflammation. False negatives: low-metabolic tumors — carcinoid, adenocarcinoma in situ, rarely metastatic kidney/prostate/testicular cancer.

MKSAP 19 B.5 Ch.1

EBUS-TBNA sensitivity: ~____% for epithelial malignancies, ~____% for lymphoma, and at least ____% for sarcoidosis.

EBUS-TBNA is the initial procedure of choice for mediastinal/hilar lymph node tissue. Sensitivity: ~90% epithelial malignancies, ~70% lymphoma, >=80% sarcoidosis (higher combined with endobronchial/transbronchial biopsies).

Harrison's 22e Ch.297; MKSAP 19 B.5 Ch.1

Normal upright-to-supine FVC fall is ____-____%; a fall of 10% to more than ____% suggests diaphragmatic weakness.

Normal FVC falls 3-8% from upright to supine. A fall of 10% to more than 25% indicates diaphragmatic weakness, hemidiaphragm paralysis, or neuromuscular disease — a sensitive bedside screen.

Harrison's 22e Ch.296

The 2023 ATS statement recommends the single race-neutral "GLI ____" reference equation for all patients.

In April 2023 the ATS recommended replacing race-specific GLI equations with the single race-neutral "GLI Global" equation for all patients, reporting results with z-scores and the LLN rather than % predicted.

Bhakta NR, et al. Am J Respir Crit Care Med 2023;207(8):978-995

Tap a card to flip it.